Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
Cimetidine
|
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells. Clinical use: peptic ulcer, gastritis, mild reflux "Take H2 blockers before you DINE. Think "table for 2" to remember H2." Toxicity: Cimetidine is a potent inhibitor of P-450; it also has antiandrogenic effects (prolactin release, gynecomastia, impotence, decreased libido in males); can cross blood-brain barrier (confusion, dizziness, headaches) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects. |
|
Ranitidine
|
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells. Clinical use: peptic ulcer, gastritis, mild reflux "Take H2 blockers before you DINE. Think "table for 2" to remember H2." Toxicity: Cimetidine is a potent inhibitor of P-450; it also has antiandrogenic effects (prolactin release, gynecomastia, impotence, decreased libido in males); can cross blood-brain barrier (confusion, dizziness, headaches) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects. |
|
Famotidine
|
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells. Clinical use: peptic ulcer, gastritis, mild reflux "Take H2 blockers before you DINE. Think "table for 2" to remember H2." Toxicity: relatively free of toxic effects of cimetidine and ranitidine. |
|
Nizatidine
|
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells. Clinical use: peptic ulcer, gastritis, mild reflux "Take H2 blockers before you DINE. Think "table for 2" to remember H2." Toxicity: relatively free of toxic effects of cimetidine and ranitidine. |
|
Omeprazole
|
PPI
Mechanism: irreversibly inhibits H/K ATPase in stomach parietal cells. Clinical use: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome. |
|
lansoprazole
|
PPI
Mechanism: irreversibly inhibits H/K ATPase in stomach parietal cells. Clinical use: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome. |
|
Bismuth
Sucralfate |
Mechanism: bind to the ulcer base, providing physical protection, and allow HCO3- secretion to reestablish pH gradient in the mucous layer.
Clinical use: Increase ulcer healing, traveler's diarrhea |
|
Triple therapy for H. Pylori Ulcers
|
Metronidazole
Amoxicillin (or Tetracycline) Bismuth Can also use PPI "Please MAke Tummy Better." |
|
Misoprostol
|
Mechanism: a PGE1 analog. increases the production and secretion of gastric mucous barrier, decreases acid production
Clinical use: prevention of NSAID-induced peptic ulcers; maintenance of patent ductus arteriosus. Also used to induce labor. Toxicity: Diarrhea. CI in women of childbearing potential (abortifacient) |
|
Pirenzepine
|
Muscarinic antagonists
Mechanism: Block M1 receptors on ECL cells (decrease histamine secretion) and M3 receptors on parietal cells (decrease H+secretion). Clinical use: peptic ulcer (rarely used) Toxicity: Tachycardia, dry mouth, difficulty focusing eyes. |
|
Propantheline
|
Muscarinic antagonists
Mechanism: Block M1 receptors on ECL cells (decrease histamine secretion) and M3 receptors on parietal cells (decrease H+secretion). Clinical use: peptic ulcer (rarely used) Toxicity: Tachycardia, dry mouth, difficulty focusing eyes. |
|
Octreotide
|
Mechanism: SST analog
Clinical use: acute variceal bleeds, acromegaly, VIPoma, carcinoid tumors Toxicity: nausea, cramps, steatorrhea |
|
Antacid use
|
Can affect absorption, bioavailability, or urinary excretion of other drugs by altering gastric and urinary pH or by delaying gastric emptying.
Overuse can also cause the following problems: I. Aluminum hydroxide-constipation and hypophosphatemia; proximal muscle weakness, osteodystrophy, seizures 2. Magnesium hydroxide-diarrhea, hyporeflexia, hypotension, cardiac arrest 3. Calcium carbonate-hypercalcemia, rebound acid increase. All can cause hypokalemia. Can chelate and decrease effectiveness of other drugs, like tetracyclines. |
|
Aluminum hydroxide
|
constipation and hypophosphatemia; proximal muscle weakness, osteodystrophy, seizures
hypokalemia "Aluminimum amount of feces" |
|
Magnesium hydroxide
|
diarrhea, hyporeflexia, hypotension, cardiac arrest
hypokalemia "Mg = must go to the bathroom" |
|
Calcium Carbonate
|
hypercalcemia,
rebound acid increase. hypokalemia |
|
Infliximab
|
Mechanism: A monoclonal antibody to TNF, proinflammatory cytokine.
Clinical use: Crohn's disease, RA Toxicity: Respiratory infection (including reactivation of latent TB), fever, hypotension. "INFLIXimab INFLIX pain on TNF." |
|
Sulfasalazine
|
mechanism: A combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflammatory). Reduces synthesis of inflammatory mediators and cytokines in the intestine, it is not absorbed.
Activated by colonic bacteria. Clinical use: UC and Crohn's disease Toxicity: malaise, nausea, sulfonamide toxicity, reversible oligospermia |
|
Ondansetron
|
Mechanism: 5-HT3 antagonist. Powerful central-acting antiemetic.
Clinical use: control vomiting post-operatively and in patients undergoing cancer chemo. Toxicity: headache, constipation "You will not vomit with ONDANSetron, so you can go ON DANCing." |
|
Metoclopramide
|
Mechanism: D2 receptor antagonist. Increases resting tone, contractility, LES tone, motility. Does NOT influence colon transport time.
Clinical use: Diabetic and post-surgery gastroparesis Toxicity: increased parkinsonian effects (D2 antag). Restlessness, drowsiness, fatigue, depression, nausea, diarrhea. Drug interaction with digoxin and diabetic agents. Contraindicated in patients with small bowel obstruction. |